Werewolf Therapeutics, Inc. (HOWL)

Werewolf Therapeutics, Inc. (HOWL) is a healthcare company (biotechnology) based in the United States. The share price is $0.99, down 0.08% on the day, which values the company at $48.11M. Price as of 17 Nov 2026, 17:26 UTC, from Yahoo Finance.

Key facts

Share price
$0.99−0.08% today
Market value
$48.11M
200-week average
$2.1454% below
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

Werewolf Therapeutics, Inc. in more detail

HOWL trades at -1.7× next year's expected earnings, 2.3× sales. It sits 54% below its 200-week average of $2.14.

In its favour: More cash than debt. Worth checking: Weak Piotroski score; Share count keeps rising.

1 of the superinvestors tracked here hold HOWL, including Peter Kolchinsky (0.0% of the portfolio).

Superinvestors holding HOWL

1 of the investors tracked here report a position in their latest 13F filing.

Werewolf Therapeutics, Inc. (HOWL): questions and answers

What is Werewolf Therapeutics, Inc.'s market cap?

Werewolf Therapeutics, Inc. is valued at $48.11M at a share price of $0.99.

Is HOWL above its 200-week moving average?

No. HOWL is 53.7% below its 200-week average of $2.14. Long-term investors watch that line because strong companies rarely trade below it for long.

Does HOWL pay a dividend?

Werewolf Therapeutics, Inc. does not currently pay a regular dividend.

Which famous investors own HOWL?

In their latest quarterly filings, Peter Kolchinsky (0.0% of the portfolio) hold HOWL. These filings are published up to 45 days after each quarter ends, so positions may have changed since.

Cite this page

Funkfolio, “Werewolf Therapeutics, Inc. (HOWL) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/HOWL

Underlying data: Yahoo Finance; company filings with the SEC.